Skip Navigation

European Heart Journal 1999 20(19):1424-1428; doi:10.1053/euhj.1999.1630
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wijbenga, J.A.M
Right arrow Articles by Hall, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wijbenga, J.A.M
Right arrow Articles by Hall, C
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice

J.A.M Wijbengaa,f1, A.H.M.M Balka, F Boomsmab, A.J Man in 't Veldb and C Hallc

a Cardiovascular Research Institute COEUR, Heart Center, University Hospital Rotterdam, Rotterdam, The Netherlands
b Cardiovascular Research Institute COEUR, Department of Internal Medicine I, University Hospital Rotterdam, Rotterdam, The Netherlands
c Institute for Surgical Research, University of Oslo, Oslo, Norway

revised March 15, 1999; accepted March 26, 1999 1999

Abstract

Aims Cardiac peptides have diagnostic and prognostic value in heart failure. Their plasma concentrations, however, are sensitive to rapid changes in haemodynamics. As blood sampling under standard conditions is not feasible in clinical practice, it is important to know which peptides are most resistant to change. Therefore, the present study investigated the differences in response to exercise between atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, brain natriuretic peptide and the recently identified N-terminal probrain natriuretic peptide.

Methods and Results Fifty-two patients with chronic heart failure performed a symptom-limited graded bicycle exercise. Blood samples for determination of plasma concentrations of cardiac peptides were drawn at rest and at peak exercise. There was a significant difference in percentage increase in response to exercise between the four peptides (P<0·0001). N-terminal proatrial natriuretic peptide increased less than atrial natriuretic peptide (5±18% vs 59±58%;P<0·0001). The difference in increase between N-terminal probrain natriuretic peptide and brain natriuretic peptide was less distinct but still significant (24±24% vs 38±52%,P <0·05).

Conclusions Both N-terminal proatrial natriuretic peptide and N-terminal probrain natriuretic peptide increased less in response to exercise than their C-terminal counterparts. This implies that the circumstances under which blood sampling for measurements of N-terminal proatrial natriuretic peptide and N-terminal probrain natriuretic peptide should be performed are more favourable than the blood sampling conditions for atrial natriuretic peptide and brain natriuretic peptide.

Key Words: Atrial natriuretic peptide, brain natriuretic peptide, peptide fragments, exercise, heart failure.

f1 Correspondence: Anke A. M. Wijbenga, MD, University Hospital Rotterdam, Room H 543, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
P. Lancellotti, B. Cosyns, and L. A. Pierard
Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure
Europace, April 1, 2008; 10(4): 496 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. D. Mainwaring, C. Parise, S. B. Wright, A. L. Juris, R. A. Achtel, and H. Fallah
Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair
Ann. Thorac. Surg., December 1, 2007; 84(6): 2066 - 2069.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EchocardiogrHome page
I. Karabinos, E. Karvouni, N. Chiotinis, A. Papadopoulos, P. Simeonidis, O. Tsolas, and D. Katritsis
Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography
Eur J Echocardiogr, August 1, 2007; 8(4): 265 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Masson, R. Latini, I. S. Anand, T. Vago, L. Angelici, S. Barlera, E. D. Missov, A. Clerico, G. Tognoni, J. N. Cohn, et al.
Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data
Clin. Chem., August 1, 2006; 52(8): 1528 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. S. Sabatine, D. A. Morrow, J. A. de Lemos, T. Omland, M. Y. Desai, M. Tanasijevic, C. Hall, C. H. McCabe, and E. Braunwald
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia
J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1988 - 1995.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. S. Mir, R. Laux, H. H. Hellwege, B. Liedke, C. Heinze, H. von Buelow, S. Laer, and J. Weil
Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth
Pediatrics, October 1, 2003; 112(4): 896 - 899.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. S. Mir, S. Marohn, S. Laer, M. Eiselt, O. Grollmus, and J. Weil
Plasma Concentrations of N-Terminal Pro-Brain Natriuretic Peptide in Control Children From the Neonatal to Adolescent Period and in Children With Congestive Heart Failure
Pediatrics, December 1, 2002; 110(6): e76 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Hulsmann, R. Berger, B. Sturm, A. Bojic, W. Woloszczuk, J. Bergler-Klein, and R. Pacher
Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure
Eur. Heart J., June 1, 2002; 23(11): 886 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Boomsma and A. H. van den Meiracker
Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use
Cardiovasc Res, August 15, 2001; 51(3): 442 - 449.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. Boomsma, J. Deinum, and A. H. van den Meiracker
Relationship between Natriuretic Peptide Concentrations in Plasma and Posture during Blood Sampling
Clin. Chem., May 1, 2001; 47(5): 963 - 965.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
M Piepoli
Editorials: Diagnostic and prognostic indicators in chronic heart failure
Eur. Heart J., October 1, 1999; 20(19): 1367 - 1369.
[PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.